Company: OTSA
Filing Date: 2025-03-26
Form Type: DRS/A
Source: 0001013762-25-002776
Chunk: 201

Company: OTSAW Ltd
Filing Date: 2025-03-26
Form: DRS/A
Chunk 201
---
 -providersystems. Dr. Olivia has a proven track record in driving operational turnarounds, strategic growth, and successful exits, with leadership roles at entities such as VNSNY, Continuum Health Alliance, and Cooper University 126 Health System. He also has significant experience in venture and private equity -backedhealthcare businesses, serving as a founder, advisor, or board member to 16 early -stagecompanies. A graduate of Penn State, Hahnemann/Drexel, and Wharton, Dr. Olivia completed his medical training at Columbia University and the University at Buffalo. Family Relationships There are no family relationships among any of our directors, director nominees or executive officers as defined in Item 401 of Regulation S -K. Employment Agreements and Director Offer Letters We plan to enter into employment agreements with each of our executive officers pursuant to which such individuals agreed to serve as our executive officers. Pursuant to these agreements, we expect to be entitled to terminate an executive officer’s employment for cause at any time. Each executive officer will agree not to, directly or indirectly, provide the same or substantially the same services that he/she provides to the Company to any other business in certain area. We also plan to enter into director offer letters with each of our independent director nominees which agreements set forth the terms and provisions of their engagement. Election of Officers Our executive officers are appointed by, and serve at the discretion of, our board of directors. Board of Directors We expect our board of directors to consist of five directors, three of whom are expected to be independent as such term is defined by the Nasdaq Capital Market. We expect that all current directors will continue to serve after this offering. The directors will be up for re -electionat our annual general meeting of shareholders. A director may vote in respect of any contract or transaction in which he is interested, provided, however that the nature of the interest of any director in any such contract or transaction shall be disclosed by him at or prior to its consideration and any vote on that matter. A general notice or disclosure to the directors or otherwise contained in the minutes of a meeting or a written resolution of the directors or any committee thereof of the nature of a director’s interest shall be sufficient disclosure and after such general notice it shall not be necessary to give special notice relating to any particular transaction. A director may be counted for a quorum upon a motion in respect of any contract or arrangement which he shall make with our company, or in which he is so interested and may vote on such motion. Board Diversity